Found: 9
Select item for more details and to access through your institution.
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Minimal residual disease as biomarker for optimal biologic dosing of ARA- C in patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 125, doi. 10.1002/ajh.23893
- By:
- Publication type:
- Article
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 5, p. 380, doi. 10.1002/ajh.21685
- By:
- Publication type:
- Article
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1083, doi. 10.3390/cancers13051083
- By:
- Publication type:
- Article
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant.
- Published in:
- Transfusion, 2010, v. 50, n. 2, p. 501, doi. 10.1111/j.1537-2995.2009.02439.x
- By:
- Publication type:
- Article
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 6, p. 1041, doi. 10.1007/s00277-018-3275-z
- By:
- Publication type:
- Article
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 3, p. 304, doi. 10.1177/1352458513498128
- By:
- Publication type:
- Article
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 58, doi. 10.1159/000448750
- By:
- Publication type:
- Article